AbbVie Succeeds In Shire Courtship With $53B Deal

  on
Shire Pharma_UK
Vitamins made by Shire are displayed at a chemist's in northwest London on July 11, 2014.

(Reuters) - Drugmaker AbbVie succeeded in buying Shire on Friday in a $53 billion deal that will allow the U.S. company to slash its tax bill by reincorporating in Britain.

AbbVie, which makes top-selling arthritis drug Humira, is paying about 52.48 pounds per share for Dublin-based Shire, made up of 24.44 pounds in cash and 0.8960 new AbbVie shares under the terms of the agreed deal.

Dublin-based Shire, which makes drugs like Vyvanse to treat hyperactivity and expensive medicines for rare diseases, on Monday said its board was ready to recommend the offer from AbbVie, signaling the end of a lengthy courtship.

Join the Discussion
Nintendo's Newest Kirby Game Is A Total Detour
Nintendo's Newest Kirby Game Is A Total Detour
Fitbit's First Activity Watch Falls Short
Fitbit's First Activity Watch Falls Short
Dying Light Is The Spiritual Successor To 'Dead Island'
Dying Light Is The Spiritual Successor To 'Dead Island'
The Last Mitsubishi Evolution
The Last Mitsubishi Evolution
The i8 Is Proof BMW Should Make More Mid-Engined Cars
The i8 Is Proof BMW Should Make More Mid-Engined Cars
QD Vision Shows Off Cheap 4K TVs
QD Vision Shows Off Cheap 4K TVs

More Video